Globus Medical Inc (GMED) 23.49 $GMED
How These Healthcare Stocks are Performing? -- Antares Pharma, Insulet, Globus Medical, and NuVasive
PR Newswire - Wed Jul 27, 7:20AM CDT
Ahead of today's trading session, Stock-Callers.com shifts focus on the Healthcare sector, which is known for its resiliency during downturns. However, current economic conditions are making it difficult for operators to manage their resources and keep up with the increasing demands. We take a look at this morning's picks and assess their performances at the close on Tuesday, July 26, 2016: Antares Pharma Inc. (NASDAQ: ATRS), Insulet Corp. (NASDAQ: PODD), Globus Medical Inc. (NYSE: GMED), and NuVasive Inc. (NASDAQ: NUVA). Learn more about these stocks by accessing their freenotes at:
PODD: 35.30 (-0.08), GMED: 23.49 (unch), NUVA: 62.63 (-0.66), ATRS: 1.08 (+0.05)
Globus Medical Reports Second Quarter 2016 Results
GlobeNewswire - Tue Jul 26, 3:30PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2016.
GMED: 23.49 (unch)
Alphatec Holdings Announces Sale of International Business to Globus Medical
GlobeNewswire - Tue Jul 26, 3:30PM CDT
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it has entered into a definitive agreement with Globus Medical (NYSE:GMED), a leading musculoskeletal implant manufacturer, whereby Globus will acquire Alphatec's international operations and distribution channel for a purchase price of $80 million. As part of the transaction, Globus has also agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
ATEC: 0.39 (-0.01), GMED: 23.49 (unch)
Globus Medical Announces the Acquisition of Alphatec's International Business
GlobeNewswire - Tue Jul 26, 3:30PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire the international operations and distribution channels of Alphatec Holdings, Inc., a publicly traded medical devices company (Nasdaq:ATEC) for $80.0 million in cash, subject to certain closing adjustments. Globus Medical also agreed to extend a 5-year senior secured credit facility of up to $30.0 million to Alphatec to support their working capital needs. The parties expect the closing of the acquisition to occur by October 2016 following satisfaction of the applicable closing conditions.
ATEC: 0.39 (-0.01), GMED: 23.49 (unch)
What Investors are Making of These Healthcare Stocks? - Antares Pharma, Globus Medical, NuVasive, and Insulet
PR Newswire - Fri Jun 24, 6:49AM CDT
Since the financial crisis, the Healthcare sector has proven to be defensive against market downturns, continuing to present opportunities for growth. Today's featured companies on Stock-Callers.com belong in this arena: Antares Pharma Inc. (NASDAQ: ATRS), Globus Medical Inc. (NYSE: GMED), NuVasive Inc. (NASDAQ: NUVA), and Insulet Corp. (NASDAQ: PODD). Learn more about these stocks and receive your complimentary trade alerts at:
PODD: 35.30 (-0.08), GMED: 23.49 (unch), NUVA: 62.63 (-0.66), ATRS: 1.08 (+0.05)
July 15th Options Now Available For Globus Medical (GMED)
DividendChannel.com - Mon May 23, 10:25AM CDT
Investors in Globus Medical Inc saw new options become available today, for the July 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GMED options chain for the new July 15th contracts and identified one...
GMED: 23.49 (unch)
Global Spine Implants Market 2016 - Forecasts To 2022 - The US Leads the Way - Research and Markets
PR Newswire Europe - Fri May 20, 12:11PM CDT
Research and Markets has announced the addition of the "Spine Implants Global Market - Forecast To 2022" [http://www.researchandmarkets.com/research/zbr323/spine_implants] report to their offering.
JNJ: 124.85 (-0.55), ZBH: 130.59 (-0.47), MDT: 87.64 (-0.42), GMED: 23.49 (unch), KTWO: 16.40 (-0.22)
Globus Medical Appoints Eric Ian Schwartz as Senior Vice President and General Counsel
GlobeNewswire - Tue May 10, 4:09PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced it appointed Eric Ian Schwartz as its Senior Vice President and General Counsel effective April 28, 2016.
GMED: 23.49 (unch)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Globus Medical, Inc. -- GMED
ACCESSWIRE - Fri May 06, 8:44AM CDT
NEW YORK, NY / ACCESSWIRE / May 6, 2016 / Levi & Korsinsky announces it has commenced an investigation of Globus Medical, Inc. (NYSE: GMED) concerning possible breaches of fiduciary duty by the Board of Directors.
GMED: 23.49 (unch)
Globus Medical beats 1Q profit forecasts
Automated Insights - Tue May 03, 4:01PM CDT
AUDUBON, Pa. (AP) _ Globus Medical Inc. (GMED) on Tuesday reported first-quarter net income of $28 million.
GMED: 23.49 (unch)
Pacific Biosciences (PACB) Q1 Loss Narrower than Expected
Zacks Equity Research - Zacks Investment Research - Fri Apr 22, 7:21AM CDT
Pacific Biosciences of California Inc. (PACB) reported a decent first-quarter 2016, thanks to the growing demand for its new Sequel system.
PACB: 8.43 (-0.19), GMED: 23.49 (unch), INGN: 52.74 (-0.26), EXAC: 27.26 (+0.06)
Globus Medical Schedules First Quarter 2016 Earnings Release and Conference Call
GlobeNewswire - Thu Apr 14, 5:47PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the first quarter ended March 31, 2016 after the market close on Tuesday, May 3, 2016. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.
GMED: 23.49 (unch)
Mazor Robotics: Strong Sell as Orders Register a Decline
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 12:00PM CDT
On Apr 14, Zacks Investment Research downgraded Mazor Robotics Ltd (MZOR) to a Zacks Rank #5 (Strong Sell).
VAR: 94.46 (-0.38), GMED: 23.49 (unch), INGN: 52.74 (-0.26), MZOR: 22.60 (+0.04)
Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 38.45 (-0.73), GMED: 23.49 (unch), ARAY: 5.47 (+0.02), ANGO: 15.30 (-1.22)
Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 23.49 (unch), MZOR: 22.60 (+0.04), ARAY: 5.47 (+0.02), ANGO: 15.30 (-1.22)
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Globus Medical, Inc. (GMED) on Behalf of Stockholders and Encourages Investors to Contact the Firm
BusinessWire - Mon Apr 04, 4:30PM CDT
Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Globus Medical, Inc. (NYSE:GMED) investors concerning whether the company's board of directors violated their fiduciary duties.
GMED: 23.49 (unch)
Globus Medical Schedules Fourth Quarter and Full Year 2015 Earnings Release and Conference Call
GlobeNewswire - Thu Feb 04, 3:15PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth quarter and full year ended December 31, 2015 after the market close on Wednesday, February 24, 2016. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.
GMED: 23.49 (unch)
Globus Medical, DePuy Synthes Settle 4 Patent Lawsuits
Zacks Equity Research - Zacks Investment Research - Wed Jan 20, 11:50AM CST
Globus Medical (GMED) recently announced the settlement of four patent infringement lawsuits with Johnson & Johnson's DePuy Synthes
ISRG: 690.49 (-3.38), JNJ: 124.85 (-0.55), GMED: 23.49 (unch), EXAC: 27.26 (+0.06)
Globus Medical Announces Litigation Settlement Agreement
GlobeNewswire - Tue Jan 19, 4:07PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced DePuy Synthes Products, Inc., DePuy Synthes Sales, Inc. and Globus Medical, Inc. have settled four patent infringement lawsuits concerning spinal implant technologies. The terms of the settlement have not been disclosed but were to the parties' mutual satisfaction.
GMED: 23.49 (unch)
EU5 Spinal Surgery Market Outlook to 2021 - Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices.
M2 - Fri Jan 15, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/drkdtm/eu5_spinal) has announced the addition of the "EU5 Spinal Surgery Market Outlook to 2021" report to their offering. "EU5 Spinal Surgery Market Outlook to 2021", provides key market data on the EU5 Spinal Surgery market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Spinal Surgery market. - Global corporate-level profiles of key companies operating within the EU5 Spinal Surgery market. - Key players covered include Medtronic, Inc., DePuy Companies, Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Orthofix International N.V., Zimmer Holdings, Inc., Biomet, Inc., Alphatec Holdings, Inc. and K2M, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Spinal Surgery Market, EU5 4 Spinal Surgery Market, France 5 Spinal Surgery Market, Germany 6 Spinal Surgery Market, Italy 7 Spinal Surgery Market, Spain 8 Spinal Surgery Market, United Kingdom 9 Overview of Key Companies in EU5 Spinal Surgery Market - Medtronic plc - DePuy Companies - Stryker Corporation - Zimmer Biomet Holdings, Inc. - B. Braun Melsungen AG - Biomet, Inc. - Alphatec Holdings, Inc. - NuVasive, Inc. - LDR Holding Corporation - Integra LifeSciences Holdings Corporation - Globus Medical, Inc. - MEDACTA Interna For more information visit http://www.researchandmarkets.com/research/drkdtm/eu5_spinal
ZMH: 113.56 (+0.29), ATEC: 0.39 (-0.01), ZBH: 130.59 (-0.47), LDRH: 36.98 (-0.02), MDT: 87.64 (-0.42), IARTV: 65.00 (-37.45), GMED: 23.49 (unch), OFIX: 42.48 (-5.04), NUVA: 62.63 (-0.66), SYK: 115.70 (-1.32)
How These Healthcare Stocks are Performing? -- Antares Pharma, Insulet, Globus Medical, and NuVasive
PR Newswire - Wed Jul 27, 7:20AM CDT
Ahead of today's trading session, Stock-Callers.com shifts focus on the Healthcare sector, which is known for its resiliency during downturns. However, current economic conditions are making it difficult for operators to manage their resources and keep up with the increasing demands. We take a look at this morning's picks and assess their performances at the close on Tuesday, July 26, 2016: Antares Pharma Inc. (NASDAQ: ATRS), Insulet Corp. (NASDAQ: PODD), Globus Medical Inc. (NYSE: GMED), and NuVasive Inc. (NASDAQ: NUVA). Learn more about these stocks by accessing their freenotes at:
PODD: 35.30 (-0.08), GMED: 23.49 (unch), NUVA: 62.63 (-0.66), ATRS: 1.08 (+0.05)
Globus Medical Reports Second Quarter 2016 Results
GlobeNewswire - Tue Jul 26, 3:30PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2016.
GMED: 23.49 (unch)
Alphatec Holdings Announces Sale of International Business to Globus Medical
GlobeNewswire - Tue Jul 26, 3:30PM CDT
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it has entered into a definitive agreement with Globus Medical (NYSE:GMED), a leading musculoskeletal implant manufacturer, whereby Globus will acquire Alphatec's international operations and distribution channel for a purchase price of $80 million. As part of the transaction, Globus has also agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
ATEC: 0.39 (-0.01), GMED: 23.49 (unch)
Globus Medical Announces the Acquisition of Alphatec's International Business
GlobeNewswire - Tue Jul 26, 3:30PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire the international operations and distribution channels of Alphatec Holdings, Inc., a publicly traded medical devices company (Nasdaq:ATEC) for $80.0 million in cash, subject to certain closing adjustments. Globus Medical also agreed to extend a 5-year senior secured credit facility of up to $30.0 million to Alphatec to support their working capital needs. The parties expect the closing of the acquisition to occur by October 2016 following satisfaction of the applicable closing conditions.
ATEC: 0.39 (-0.01), GMED: 23.49 (unch)
What Investors are Making of These Healthcare Stocks? - Antares Pharma, Globus Medical, NuVasive, and Insulet
PR Newswire - Fri Jun 24, 6:49AM CDT
Since the financial crisis, the Healthcare sector has proven to be defensive against market downturns, continuing to present opportunities for growth. Today's featured companies on Stock-Callers.com belong in this arena: Antares Pharma Inc. (NASDAQ: ATRS), Globus Medical Inc. (NYSE: GMED), NuVasive Inc. (NASDAQ: NUVA), and Insulet Corp. (NASDAQ: PODD). Learn more about these stocks and receive your complimentary trade alerts at:
PODD: 35.30 (-0.08), GMED: 23.49 (unch), NUVA: 62.63 (-0.66), ATRS: 1.08 (+0.05)
July 15th Options Now Available For Globus Medical (GMED)
DividendChannel.com - Mon May 23, 10:25AM CDT
Investors in Globus Medical Inc saw new options become available today, for the July 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GMED options chain for the new July 15th contracts and identified one...
GMED: 23.49 (unch)
Global Spine Implants Market 2016 - Forecasts To 2022 - The US Leads the Way - Research and Markets
PR Newswire Europe - Fri May 20, 12:11PM CDT
Research and Markets has announced the addition of the "Spine Implants Global Market - Forecast To 2022" [http://www.researchandmarkets.com/research/zbr323/spine_implants] report to their offering.
JNJ: 124.85 (-0.55), ZBH: 130.59 (-0.47), MDT: 87.64 (-0.42), GMED: 23.49 (unch), KTWO: 16.40 (-0.22)
Globus Medical Appoints Eric Ian Schwartz as Senior Vice President and General Counsel
GlobeNewswire - Tue May 10, 4:09PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced it appointed Eric Ian Schwartz as its Senior Vice President and General Counsel effective April 28, 2016.
GMED: 23.49 (unch)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Globus Medical, Inc. -- GMED
ACCESSWIRE - Fri May 06, 8:44AM CDT
NEW YORK, NY / ACCESSWIRE / May 6, 2016 / Levi & Korsinsky announces it has commenced an investigation of Globus Medical, Inc. (NYSE: GMED) concerning possible breaches of fiduciary duty by the Board of Directors.
GMED: 23.49 (unch)
Globus Medical beats 1Q profit forecasts
Automated Insights - Tue May 03, 4:01PM CDT
AUDUBON, Pa. (AP) _ Globus Medical Inc. (GMED) on Tuesday reported first-quarter net income of $28 million.
GMED: 23.49 (unch)
Pacific Biosciences (PACB) Q1 Loss Narrower than Expected
Zacks Equity Research - Zacks Investment Research - Fri Apr 22, 7:21AM CDT
Pacific Biosciences of California Inc. (PACB) reported a decent first-quarter 2016, thanks to the growing demand for its new Sequel system.
PACB: 8.43 (-0.19), GMED: 23.49 (unch), INGN: 52.74 (-0.26), EXAC: 27.26 (+0.06)
Globus Medical Schedules First Quarter 2016 Earnings Release and Conference Call
GlobeNewswire - Thu Apr 14, 5:47PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the first quarter ended March 31, 2016 after the market close on Tuesday, May 3, 2016. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.
GMED: 23.49 (unch)
Mazor Robotics: Strong Sell as Orders Register a Decline
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 12:00PM CDT
On Apr 14, Zacks Investment Research downgraded Mazor Robotics Ltd (MZOR) to a Zacks Rank #5 (Strong Sell).
VAR: 94.46 (-0.38), GMED: 23.49 (unch), INGN: 52.74 (-0.26), MZOR: 22.60 (+0.04)
Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 38.45 (-0.73), GMED: 23.49 (unch), ARAY: 5.47 (+0.02), ANGO: 15.30 (-1.22)
Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 23.49 (unch), MZOR: 22.60 (+0.04), ARAY: 5.47 (+0.02), ANGO: 15.30 (-1.22)
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Globus Medical, Inc. (GMED) on Behalf of Stockholders and Encourages Investors to Contact the Firm
BusinessWire - Mon Apr 04, 4:30PM CDT
Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Globus Medical, Inc. (NYSE:GMED) investors concerning whether the company's board of directors violated their fiduciary duties.
GMED: 23.49 (unch)
Globus Medical Schedules Fourth Quarter and Full Year 2015 Earnings Release and Conference Call
GlobeNewswire - Thu Feb 04, 3:15PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth quarter and full year ended December 31, 2015 after the market close on Wednesday, February 24, 2016. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.
GMED: 23.49 (unch)
Globus Medical, DePuy Synthes Settle 4 Patent Lawsuits
Zacks Equity Research - Zacks Investment Research - Wed Jan 20, 11:50AM CST
Globus Medical (GMED) recently announced the settlement of four patent infringement lawsuits with Johnson & Johnson's DePuy Synthes
ISRG: 690.49 (-3.38), JNJ: 124.85 (-0.55), GMED: 23.49 (unch), EXAC: 27.26 (+0.06)
Globus Medical Announces Litigation Settlement Agreement
GlobeNewswire - Tue Jan 19, 4:07PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced DePuy Synthes Products, Inc., DePuy Synthes Sales, Inc. and Globus Medical, Inc. have settled four patent infringement lawsuits concerning spinal implant technologies. The terms of the settlement have not been disclosed but were to the parties' mutual satisfaction.
GMED: 23.49 (unch)
EU5 Spinal Surgery Market Outlook to 2021 - Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices.
M2 - Fri Jan 15, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/drkdtm/eu5_spinal) has announced the addition of the "EU5 Spinal Surgery Market Outlook to 2021" report to their offering. "EU5 Spinal Surgery Market Outlook to 2021", provides key market data on the EU5 Spinal Surgery market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Spinal Surgery market. - Global corporate-level profiles of key companies operating within the EU5 Spinal Surgery market. - Key players covered include Medtronic, Inc., DePuy Companies, Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Orthofix International N.V., Zimmer Holdings, Inc., Biomet, Inc., Alphatec Holdings, Inc. and K2M, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Spinal Surgery Market, EU5 4 Spinal Surgery Market, France 5 Spinal Surgery Market, Germany 6 Spinal Surgery Market, Italy 7 Spinal Surgery Market, Spain 8 Spinal Surgery Market, United Kingdom 9 Overview of Key Companies in EU5 Spinal Surgery Market - Medtronic plc - DePuy Companies - Stryker Corporation - Zimmer Biomet Holdings, Inc. - B. Braun Melsungen AG - Biomet, Inc. - Alphatec Holdings, Inc. - NuVasive, Inc. - LDR Holding Corporation - Integra LifeSciences Holdings Corporation - Globus Medical, Inc. - MEDACTA Interna For more information visit http://www.researchandmarkets.com/research/drkdtm/eu5_spinal
ZMH: 113.56 (+0.29), ATEC: 0.39 (-0.01), ZBH: 130.59 (-0.47), LDRH: 36.98 (-0.02), MDT: 87.64 (-0.42), IARTV: 65.00 (-37.45), GMED: 23.49 (unch), OFIX: 42.48 (-5.04), NUVA: 62.63 (-0.66), SYK: 115.70 (-1.32)
